ARWR 8-K 2026-01-08

ARROWHEAD PHARMACEUTICALS, INC. (ARWR) 8-K dated 2026-01-08 — accession 0001193125-26-007971. This URL is the filing, not the ARWR hub.

ARROWHEAD PHARMACEUTICALS, INC. (ARWR) is a biotechnology company listed on US.

ARROWHEAD PHARMACEUTICALS, INC. filed a 8-K on 2026-01-08. Accession 0001193125-26-007971.

Cached items: 1.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ARWR revenue for 2025-09-30 was $829.4M. Net income was $30.1M. Revenue was up 23258.2% from 2024-09-30 to 2025-09-30. ARWR currently screens at market cap $10.59B.

Not investment advice. The ARWR SEC hub lists recent forms. The stock page is the research view.